Nutrition vs Safety: Omega 3 Oils and Mercury in Seafood
Nutrition vs Safety: Omega 3 Oils and Mercury in Seafood Read More »
Uncategorized
The Economist: The business of HIV – Battling the virus- A huge, strange drug market
If the process for developing HIV drugs has been unusual, selling them has been even more so. America is the rich world’s biggest market, with 841,000 patients diagnosed—ten times as many as in Britain. More than 60% of HIV drugs in America are bought with public money. Insurers give HIV special treatment: patients are rarely
The Economist: The business of HIV – Battling the virus- A huge, strange drug market Read More »
Heart Disease and HIV- What to Do?
Some HIV+ people have emailed me worried about this report: Heart Attacks Found Early and Frequently in HIV Positive People Calculate your 5 year estimated cardiovascular risk: D-A-D Cardiovascular Risk Equation for HIV+ People My suggestions to minimize heart disease (not in any other of importance): 1- Do not smoke 2- Keep your cholesterol and triglycerides within normal ranges
Heart Disease and HIV- What to Do? Read More »
The Stigma Project Social Media Campaigns
I want to congratulate the Stigma Project (https://www.thestigmaproject.org ) for their great campaigns to fight stigma. I particularly love this last ad called “Clean UB2” On the internet, HIV negative (or those who do not know their status) often refer to themselves as “clean” or DDF (drug and disease free), two terms that really stigmatize HIV
The Stigma Project Social Media Campaigns Read More »
Nucleoside and Norvir Free HIV Medication Regimen May Provide an Option for Patients with Kidney Problems
https://www.hivandhepatitis.com/hiv-aids/hiv-aids-topics/hiv-treatment/3629-nrti-sparing-art-with-atazanavir-raltegravir-conflicting-data-for-naive-and-experienced-patients NRTI-sparing antiretroviral regimen of unboosted atazanavir (Reyataz) plus raltegravir (Isentress) suppresses HIV in treatment-naive patients as well as standard 3-drug combinations, but its twice-daily dosing, side effects, and low barrier to resistance limit its appeal. For treatment-experienced people already doing well on atazanavir triple therapy, however, the dual regimen may be an attractive simplification
Please Sign this Petition for More CURE Research Funding
Sign this Petition to Ask Obama for More HIV Cure Research Funding
Please Sign this Petition for More CURE Research Funding Read More »
Nelson, how is the man who got cured of HIV (The Berlin Patient) doing ?
Nelson, How is Timothy Brown doing? Jun 13, 2012 I have read some of your post about Timothy Brown, the guy who was cured of HIV. I was shocked to find out he has been struggling here in the United States after he moved from Germany. How is he doing now? How is his health?
Nelson, how is the man who got cured of HIV (The Berlin Patient) doing ? Read More »
HIV Drug May Slow Down Metastatic Breast Cancer
A class of HIV antiretroviral drugs known as CCR5 antagonists — which includes maraviroc (Selzentry) and vicriviroc — inhibit the invasion or spread of specific types of breast cancer cells that express CCR5 receptors, according to findings from a laboratory study published in the May 25, 2012, advance online edition of Cancer Research. Click here
HIV Drug May Slow Down Metastatic Breast Cancer Read More »
Tips from Long Term Survivors for Taking Your Medications on Time
Staying on top of your treatment every day is not an easy task. Annoying side effects, being disorganized and the hustle and bustle of life can stand in your way. So we took to the streets to ask HIV experts and people living with HIV to talk about why adherence is important and to share
Tips from Long Term Survivors for Taking Your Medications on Time Read More »
New HIV Drugs in the Pipeline – 2012
Gilead has completed and released 48-week data from ongoing phase 3 studies of a four-drug fixed dose combination (elvitegravir, cobicistat, tenofovir, and FTC- called QUAD), as it has with studies of the integrase inhibitor elvitegravir and the pharmacokinetic booster cobicistat. QUAD will likely be approved for treatment naive patients after August this year. Results from
New HIV Drugs in the Pipeline – 2012 Read More »
PoWeR Resources
I wanted to remind everyone about resources from Program for Wellness Restoration (PoWeR). Regards, Nelson Vergel Director Sites: https://www.powerusa.org/ https://www.facialwasting.org/ https://www.testosteronewisdom.com/ https://www.agingwithhiv.org/ https://www.salvagetherapies.org/ Groups: https://www.facebook.com/groups/testosteronereplacement/ https://health.groups.yahoo.com/group/PozHealth/ https://www.facebook.com/groups/egrifta/ https://www.facebook.com/HIVCure https://www.facebook.com/PoWeRUSA Ask questions: https://www.thebody.com/Forums/AIDS/Aging/ask.html Twitter: https://twitter.com/#!/nelsonvergel Doctor’s Lists, Directories, Compounding pharmacy, etc: https://powerusa.org/resources.html Upcoming: ShortcuttoShape.com